Reports

Featured reports

Cancer in Australia 2017  

Cancer in Australia 2017 presents the latest available information on national population screening programs, Medicare data, cancer incidence, hospitalisations, survival, prevalence, mortality and burden of disease. Cancer is the leading cause of disease burden in Australia.

Brain and other central nervous system cancers 

This report is the first national report to present key data specific to brain and other central nervous system (CNS) cancer. While brain and other CNS cancer is rare, it has a substantial social and economic impact on individuals, families and community. Non malignant brain and other CNS tumours also cause significant morbidity and mortality.

Australian Cancer Incidence and Mortality (ACIM) books 

The ACIM books are Excel workbooks of summary statistics, tables and graphs by age, year, sex, and state and territory for selected cancers and all cancers combined. In this 2017 release, the ACIM books present data by state and territory for the first time.

Cancer screening in Australia by small geographic areas 2015–2016 

Cancer screening programs aim to reduce illness and death resulting from cancer through an organised approach to screening. These tables present the latest participation data for Australia’s three cancer screening programs: the National Bowel Cancer Screening Program, BreastScreen Australia, and the National Cervical Screening Program by small geographic areas.

Radiotherapy in Australia 2015–16 

In 2015–16, 60,600 courses of radiotherapy were delivered in Australia. For non-emergency treatment, 50% of patients started treatment within 9 days, and 90% within 27 days. For those who needed emergency treatment, 91% began treatment within the emergency timeframe. Data covered effectively 100% of courses delivered in Australia.

Cancer screening in Australia: participation data 

Cancer screening programs aim to reduce illness and death resulting from cancer through an organised approach to screening. These tables present the latest participation data for Australia’s three cancer screening programs: BreastScreen Australia, National Cervical Screening Program and National Bowel Cancer Screening Program.

Burden of cancer in Australia: Australian Burden of Disease Study 2011 

Cancer was the greatest cause of health burden in Australia in 2011, accounting for around one-fifth of the total disease burden. Most (94%) of this burden was due to dying prematurely, with only a small proportion of the burden due to living with a cancer diagnosis. This report explores in further detail the burden of cancer in Australia, including cancer burden in Aboriginal and Torres Strait islander people, and by remoteness and socioeconomic group. It also looks at how the cancer burden has changed since 2003, and the potential burden of cancer expected in 2020.

National Cervical Screening Program Data Dictionary version 1.0 

The National Cervical Screening Program aims to reduce incidence, morbidity and mortality from cervical cancer in Australia. A new National Cervical Screening Program is scheduled to commence on 1 December 2017—this new National Cervical Screening Program data dictionary is a key document that has been developed by the Australian Institute of Health and Welfare with the assistance of state and territory cervical screening programs and other cervical screening experts, to support monitoring and reporting by the Australian Institute of Health and Welfare for the new National Cervical Screening Program.

National Bowel Cancer Screening Program: monitoring report 2017 

This report presents statistics on the National Bowel Cancer Screening Program (NBCSP) using key performance indicators. Of those who were invited to participate in the NBCSP between 1 January 2014 and 31 December 2015, 39% undertook screening. For those screened in 2015, 8% had a positive result warranting further assessment. One in 29 participants who underwent a follow-up diagnostic assessment was diagnosed with a confirmed or suspected cancer.

Cervical screening in Australia 2014–2015 

Cervical screening in Australia 2014–2015 presents the latest national statistics monitoring the National Cervical Screening Program, which aims to reduce incidence, morbidity and mortality from cervical cancer. Just over half (56%) of women in the target age group of 20–69 took part in the program, with more than 3.8 million women screening in 2014 and 2015. Cervical cancer incidence for women of all ages remains at an historical low of 7 new cases per 100,000 women, and deaths are also low, historically and by international standards, at 2 deaths per 100,000 women.

Cancer compendium: information and trends by cancer type 

This report present key data, information and trends over time for 14 key cancers and all cancers combined. For all cancers combined, the number of new cases of cancer diagnosed increased from 47,445 in 1982 to 124,465 in 2013. Individuals with cancer had an increased chance of survival (from 48% in 1984–1988 to 68% in 2009–2013) compared to their counterparts in the general Australian population.

Cancer in Australia: in brief 2017 

Cancer in Australia: in brief 2017 presents key points and trends from the Australian Institute of Health and Welfare’s latest biennial report about cancer in Australia, Cancer in Australia 2017.

Cancer incidence in Australia by small geographic areas 

This dynamic data display report card provides a quick, at-a-glance view of cancer incidence and mortality in Australia by Primary Health Network (PHN) and Statistical Area Level 3 (SA3) for all cancers combined, and six selected cancers.

Cancer Incidence and Mortality Across Regions (CIMAR) books 

The Cancer Incidence and Mortality Across Regions (CIMAR) books are Excel workbooks that present cancer incidence and mortality statistics (counts, populations, crude rates, age-standardised rates and rate ratios) for selected cancers across various geographical areas.

Radiotherapy in Australia: report on the second year of a pilot collection 2014–15 

In this report on the second pilot year collection of national radiotherapy data, data were received from 66 out of 74 service locations across Australia. These services contributed information on over 56,400 courses of radiotherapy delivered in 2014–15. For non-emergency treatment, 50% of patients started treatment within 10 days and 90% started within 28 days. For those who needed emergency treatment, 91% began treatment within the emergency timeframe.

Fourth study of mortality and cancer incidence in aircraft maintenance personnel: a continuing study of F-111 Deseal/Reseal personnel 2016 

Between 1974 and 2000, the Royal Australian Air Force undertook a series of formal Deseal/Reseal (DSRS) programs, alongside informal repair activities, to correct fuel leaks inside the fuel tanks of F-111 aircraft. A number of concerns were raised about health outcomes in personnel who worked on these programs and associated activities. The repair work was suspended in 2000, and a series of inquiries and health studies followed. This report presents the findings of the fourth iteration of a series of studies on mortality and cancer incidence of F-111 DSRS personnel. The report will be a valuable resource for policy makers, program managers and health professionals interested in health outcomes of Australian Defence Force personnel.

BreastScreen Australia monitoring report 2013–2014 

The BreastScreen Australia monitoring report 2013–2014 presents the latest national statistics monitoring BreastScreen Australia, which aims to reduce illness and death resulting from breast cancer through organised screening to detect cases of unsuspected breast cancer in women, thus enabling early intervention. Around 54% of women in the target age group of 50–69 took part in the program, with more than 1.4 million women screening in 2013–2014. Breast cancer mortality is at a historic low, at 42 deaths per 100,000 women.

National Bowel Cancer Screening Program: monitoring report 2016 

This report presents statistics on the National Bowel Cancer Screening Program (NBCSP). This monitoring report is the first to measure the NBCSP using NBCSP key performance indicators. The goal of the NBCSP is to reduce the morbidity and morality from bowel cancer by activtly recruiting and screening the target population for early detection or prevention of the disease.

Skin cancer in Australia 

Skin cancer (melanoma and non-melanoma skin cancers) accounts for the largest number of cancers diagnosed in Australia each year. This report provides an overview of skin cancer in Australia, risk factors, and key summary measures, including incidence, hospitalisations, survival and mortality.

Radiotherapy in Australia: report on a pilot data collection 2013–14 

In this report on the first pilot year collection of national radiotherapy data, data were received from 53 (out of 72) service locations across Australia. These services contributed information about 47,700 courses of radiotherapy delivered in 2013–14. For non-emergency treatment, 50% of patients started treatment within 13 days and 90% started within 33 days. For those who needed emergency treatment, 90% began treatment within the emergency timeframe.